Rajendra Lingala

517 total citations
21 papers, 206 citations indexed

About

Rajendra Lingala is a scholar working on Epidemiology, Small Animals and Molecular Biology. According to data from OpenAlex, Rajendra Lingala has authored 21 papers receiving a total of 206 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Small Animals and 6 papers in Molecular Biology. Recurrent topics in Rajendra Lingala's work include Brucella: diagnosis, epidemiology, treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Bacteriophages and microbial interactions (4 papers). Rajendra Lingala is often cited by papers focused on Brucella: diagnosis, epidemiology, treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Bacteriophages and microbial interactions (4 papers). Rajendra Lingala collaborates with scholars based in India, United Kingdom and United States. Rajendra Lingala's co-authors include V.A. Srinivasan, Dev Chandran, Rajan Sriraman, D. Thiagarajan, John T. Schiller, Yuk‐Ying S. Pang, Nagendrakumar B. Singanallur, Kapil Maithal, David J. Paton and M. Hema and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Biochemistry and Vaccine.

In The Last Decade

Rajendra Lingala

19 papers receiving 192 citations

Peers

Countries citing papers authored by Rajendra Lingala

Since Specialization

Citations

This map shows the geographic impact of Rajendra Lingala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajendra Lingala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajendra Lingala more than expected).

Fields of papers citing papers by Rajendra Lingala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajendra Lingala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajendra Lingala. The network helps show where Rajendra Lingala may publish in the future.

Co-authorship network of co-authors of Rajendra Lingala

This figure shows the co-authorship network connecting the top 25 collaborators of Rajendra Lingala. A scholar is included among the top collaborators of Rajendra Lingala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajendra Lingala. Rajendra Lingala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structure–activity relationships of fenarimol analogues with potent in vitro and in vivo activity against Madurella mycetomatis , the main causative agent of mycetoma 2025 ·RSC Medicinal Chemistry ·(unknown), (unknown), Wilson Lim, (unknown), (unknown), Rajendra Lingala, Benjamin I. Perry, (unknown), Rahman Shah Zaib Saleem, Peter J. Rutledge, Alice Motion, Wendy W. J. van de Sande, Matthew H. Todd	0
2	Immunogenicity and safety of HavisureTM vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study 2023 ·Vaccine ·(unknown), Madhu Gupta, Kheya Ghosh Uttam, Sonali Palkar, (unknown), (unknown), (unknown), Mandyam Dhati Ravi, (unknown), (unknown), (unknown), (unknown), Rajendra Lingala, (unknown), (unknown)	0
3	Safety and immunogenicity of inactivated hepatitis-A vaccine developed by Human Biologicals Institute in two age groups of healthy subjects: A phase I open label study 2021 ·Vaccine ·(unknown), Sonali Palkar, (unknown), Arundhati Diwan, (unknown), (unknown), (unknown), (unknown), Rajendra Lingala, (unknown)	1
4	Evaluation of immunogenicity and protective efficacy of a liposome containing Brucella abortus S19 outer membrane protein in BALB/c mice. 2016 ·PubMed ·(unknown), A. Krishna Prasad, (unknown), Samir Kumar Rana, Rajendra Lingala, Girish Sharma, V.A. Srinivasan	8
5	Assessment of packed bed bioreactor systems in the production of viral vaccines 2014 ·AMB Express ·R. Rajendran, Rajendra Lingala, (unknown), (unknown), (unknown), (unknown), Stéphanie Dubois, (unknown), Kapil Maithal	23
6	Generation and characterization of neutralizing monoclonal antibodies against baculo-expressed HPV 16 VLPs 2014 ·European Journal of Microbiology and Immunology ·(unknown), (unknown), Sharmila Rajan, (unknown), (unknown), Abhinay Gontu, (unknown), (unknown), Rajendra Lingala	8
7	Recombinant human antibody fragment against tetanus toxoid produced by phage display 2014 ·European Journal of Microbiology and Immunology ·(unknown), N. Sridevi, (unknown), (unknown), (unknown), Rajendra Lingala	9
8	E6 protein of human papillomavirus 16 (HPV16) expressed in Escherichia coli sans a stretch of hydrophobic amino acids, enables purification of GST-ΔE6 in the soluble form and retains the binding ability to p53 2013 ·Protein Expression and Purification ·(unknown), Rajan Sriraman, Samir Kumar Rana, (unknown), (unknown), (unknown), Rajendra Lingala, (unknown), (unknown)	5
9	A simple and rapid method to monitor the disassembly and reassembly of virus-like particles 2013 ·Analytical Biochemistry ·(unknown), (unknown), Rajan Sriraman, (unknown), Rajendra Lingala, (unknown)	4
10	A novel site-II directed glycoprotein estimation ELISA to aid rabies vaccine manufacture for veterinary and human use 2013 ·Vaccine ·Abhinay Gontu, Scott Dessain, (unknown), Rajappa Senthilkumar, (unknown), (unknown), Ramesh Reddy, (unknown), Rajendra Lingala	7
11	A Brucella abortus S19 Glyco-conjugate Vaccine Consisting of Lipopolysaccharide and outer Membrane Protein Protects Mice against Challenge with Brucella abortus 2012 ·SHILAP Revista de lepidopterología ·(unknown), Rajendra Lingala, (unknown)	2
12	Development of recombinant single-chain variable fragment against hepatitis A virus and its use in quantification of hepatitis A antigen 2012 ·Biologicals ·(unknown), (unknown), (unknown), (unknown), Rajendra Lingala, Dev Chandran, (unknown)	3
13	Development and Comparative Evaluation of a Competitive ELISA with Rose Bengal Test and a Commercial Indirect ELISA for Serological Diagnosis of Brucellosis 2011 ·Indian Journal of Microbiology ·(unknown), Rajendra Lingala, (unknown), D. Thiagarajan, V.A. Srinivasan	12
14	Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles 2011 ·Vaccine ·(unknown), (unknown), Rajendra Lingala, Rajan Sriraman, Yuk‐Ying S. Pang, John T. Schiller, V.A. Srinivasan	37
15	Generation and Characterization of an scFv Directed against Site II of Rabies Glycoprotein 2011 ·PubMed ·(unknown), (unknown), (unknown), (unknown), Dev Chandran, Rajendra Lingala, (unknown)	9
16	MVA recombinants expressing the fusion and hemagglutinin genes of PPRV protects goats against virulent challenge 2010 ·Indian Journal of Microbiology ·Dev Chandran, (unknown), (unknown), (unknown), (unknown), (unknown), Rajendra Lingala, V.A. Srinivasan	20
17	Immunocapture Enzyme-Linked Immunosorbent Assay for Assessment of I n V itro Potency of Recombinant Hepatitis B Vaccines 2010 ·Clinical and Vaccine Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), Nagendrakumar B. Singanallur, Rajendra Lingala, (unknown), (unknown)	16
18	Optimization of production of Brucella abortus S19 culture in bioreactor using soyabean casein digest medium. 2010 ·PubMed ·(unknown), Rajendra Lingala, (unknown), V.A. Srinivasan	1
19	A combined vaccine against Brucella abortus and infectious bovine rhinotracheitis 2009 ·Indian Journal of Microbiology ·(unknown), (unknown), Rajendra Lingala, V.A. Srinivasan	1
20	Chimeric tymovirus-like particles displaying foot-and-mouth disease virus non-structural protein epitopes and its use for detection of FMDV-NSP antibodies 2007 ·Vaccine ·M. Hema, Nagendrakumar B. Singanallur, (unknown), Dev Chandran, Rajendra Lingala, D. Thiagarajan, Satya Parida, David J. Paton, V.A. Srinivasan	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact